MedTrace Logo

Effectiveness and Safety Evaluation of Aqueduct 100-device

NCT02959567 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-11-09

No results posted yet for this study

Summary

Evaluation of efficacy and safety of using Aqueduct -100 - Cervical Dilator Device, focusing on diagnostic or operative hysteroscopies.

Conditions

  • Cervix Uteri Dilation

Interventions

DEVICE

Aqueduct 100 dilation

Sponsors & Collaborators

  • Aqueduct Medical Ltd

    lead INDUSTRY

Principal Investigators

  • Larry Spiegelman, Dr. · Baptist Medical Arts Surgical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959567 on ClinicalTrials.gov